BCM
NTRP

Bluefin Capital Management’s Neurotrope, Inc. Common NTRP Stock Holding History

Bluefin Capital Management’s Portfolio NTRP Stock Details NTRP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-60,100
Closed -$1K – 779
2019
Q3 		$1K Buy
60,100
+10,000
+20% +$45.9K ﹤0.01% 505
2019
Q2 		$213K Buy
+50,100
New +$337K 0.03% 221

Other funds holding NTRP

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CC
Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return
NRS
Neville Rodie & Shaw New York $1.55B AUM 46.95% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
LTFS
Ladenburg Thalmann Financial Services Miami, Florida $15.9B AUM 25.16% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Bluefin Capital Management's NTRP Position: Q3 2019 in Review

Bluefin Capital Management sold out of Neurotrope, Inc. Common (NTRP) in Q3 2019, closing a stake of 42,805 shares — an estimated $196K sold.

Bluefin Capital Management first reported a position in NTRP in Q2 2019 and held it in 1 quarter. The position peaked at $343K in Q2 2019. 29 funds tracked by Wall St. Rank hold NTRP as of Q3 2019.

  • Bluefin Capital Management reported no remaining Neurotrope, Inc. Common position as of Q3 2019 after selling out during the quarter.
  • Bluefin Capital Management sold 42,805 Neurotrope, Inc. Common shares in Q3 2019, an estimated $196K.
  • Bluefin Capital Management first reported a position in Neurotrope, Inc. Common in Q2 2019 and held it in 1 quarter.
  • Bluefin Capital Management's Neurotrope, Inc. Common position peaked at $343K in Q2 2019.
  • 29 funds tracked by Wall St. Rank held Neurotrope, Inc. Common as of Q3 2019.

Based on Bluefin Capital Management's 13F filing for Q3 2019, filed 15 Nov 2019.